胎児モニタリング市場 : 2027年までの世界予測

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2023年 1月

胎児モニタリング市場 : 製品 (超音波、胎児モニター、遠隔測定装置、胎児用心電図)、携帯性 (携帯型、非携帯型)、方法 (侵襲的、非侵襲的)、用途 (分娩前、分娩中)、エンドユーザー、地域別 – 2027年までの世界予測
Fetal Monitoring Market by Product (Ultrasound, Fetal Monitors, Telemetry Devices, Fetal Electrodes), Portability (Portable, Non-portable), Method (Invasive, Non-invasive), Application (Antepartum, Intrapartum), End User, Region – Global Forecast to 2027

ページ数 238
図表数 263
種別 英文調査報告書
価格

レポート目次    お問合せ・ご注文    価格・納期について

無料サンプル

The global fetal monitoring market is projected to reach USD 5.2 Billion by 2027 from USD 3.7 Billion in 2022, at a CAGR of 7.3% during the forecast period. Growth in this market is mainly driven by the technological advancements in fetal monitoring products, and the rise in number of gynecological clinics.

胎児モニタリング市場 : 製品 (超音波、胎児モニター、遠隔測定装置、胎児用心電図)、携帯性 (携帯型、非携帯型)、方法 (侵襲的、非侵襲的)、用途 (分娩前、分娩中)、エンドユーザー、地域別 - 2027年までの世界予測 Fetal Monitoring Market by Product (Ultrasound, Fetal Monitors, Telemetry Devices, Fetal Electrodes), Portability (Portable, Non-portable), Method (Invasive, Non-invasive), Application (Antepartum, Intrapartum), End User, Region - Global Forecast to 2027
“The electronic maternal/fetal monitors accounted for the highest growth rate in the fetal monitoring market, by product, during the forecast period.”
Based on products, the fetal monitoring market is segmented into ultrasound devices, electronic maternal/fetal monitors, fetal electrodes, fetal doppler devices, uterine contraction monitors, telemetry devices, accessories & consumables, and other products. The fastest-growing segment in this market during the forecast period is the fetal monitors. This segment’s growth can primarily be attributed to the rising congenital anomalies.
“Non-portable systems segment accounted for the highest CAGR.”
Based on portability, the market is segmented into non-portable systems and portable systems. In 2021, non-portable systems accounted for the largest share because it has more number of applications in hospitals for maternal and fetal well being.
“The hospitals accounted for the highest growth rate in the fetal monitoring market, by end user, during the forecast period.”
The market is segmented into hospitals, obstetrics & gynecology clinics, and home care settings based on end users. In 2021, hospitals accounted for the largest share of this market. The growth of this segments can be attributed to the growing number of births and pregnancies, and initiatives by government for new tools and devices in hospitals.
“Asia Pacific: The fastest-growing region fetal monitoring market.”
The global fetal monitoring market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2021, North America was the largest regional market for fetal monitoring. The presence of key players in the region and the better healthcare facilities are the major factors supporting the growth of the fetal monitoring market in North America. However, the Asia Pacific region offers high-growth opportunities for players in the fetal monitoring market. This regional segment is projected to register the highest CAGR during the forecast period. Factors such as ongoing product approvals and launches in the region are factors driving the market growth in the region.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
• By Designation: C-level – 27%, D-level – 18%, and Others – 55%
• By Region: North America – 51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6%, and the Middle East & Africa – 4%
Lists of Companies Profiled in the Report:

• Cardinal Health, Inc. (US)
• Koninklijke Philips N.V. (Netherlands)
• GE Healthcare (US)
• Siemens Healthineers (Germany)
• FUJIFILM SonoSite, Inc. (US)
• Natus Medical Incorporated (US)
• Huntleigh Healthcare Limited (UK)
• The Cooper Companies Inc. (US)
• CONTEC Medical Systems Co., Ltd. (China)
• EDAN Instruments, Inc. (China)
• Neoventa Medical AB (Sweden)
• Bionet Co., Ltd. (South Korea)
• Progetti Srl (Italy)
• TRISMED Co., Ltd. (Republic of Korea)
• ShenZhen Luckcome Technology Inc. (China)
• MedGyn Products, Inc (US)
• Dixion (Germany)
• Promed Group Co., Ltd. (Hong Kong)
• Advanced Instrumentations (US)
• BRAEL-Medical Equipment (Poland)
• GPC Medical (India)
• BISTOS (Korea)
• Mediana Co. Ltd (Korea)
• Life Plus Medical (India)
• ChoiceMMed (China)
• Trivitron Healthcare (India)
• Dott Medical Co. Ltd. (China)
• Shenzhen Comen Medical Instruments Co., Ltd. (China)
• Shenzhen Vcomin Technology Limited (China)
• Nemo Healthcare (Netherlands)
• MindChild Medical, Inc. (US)
• Melody International Ltd. (Japan)
• Janitri Innovations Pvt. Ltd. (India)
• Laerdal Global Health (Norway)

胎児モニタリング市場 : 製品 (超音波、胎児モニター、遠隔測定装置、胎児用心電図)、携帯性 (携帯型、非携帯型)、方法 (侵襲的、非侵襲的)、用途 (分娩前、分娩中)、エンドユーザー、地域別 - 2027年までの世界予測 Fetal Monitoring Market by Product (Ultrasound, Fetal Monitors, Telemetry Devices, Fetal Electrodes), Portability (Portable, Non-portable), Method (Invasive, Non-invasive), Application (Antepartum, Intrapartum), End User, Region - Global Forecast to 2027
Research Coverage:
This report provides a detailed picture of the global fetal monitoring market. It aims at estimating the size and future growth potential of the market across different segments, such as product, portability, method, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall fetal monitoring market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges


目次

1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 31
TABLE 1 INCLUSIONS AND EXCLUSIONS 32
1.3 STUDY SCOPE 32
1.3.1 YEARS CONSIDERED 33
1.4 CURRENCY CONSIDERED 33
TABLE 2 USD EXCHANGE RATES 33
1.5 STAKEHOLDERS 34
1.6 SUMMARY OF CHANGES 34
1.7 LIMITATIONS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
FIGURE 1 FETAL MONITORING MARKET: RESEARCH DESIGN METHODOLOGY 36
2.1.1 SECONDARY DATA 37
2.1.1.1 Secondary sources 38
2.1.2 PRIMARY DATA 38
FIGURE 2 PRIMARY SOURCES 38
TABLE 3 KEY DATA FROM PRIMARY SOURCES 39
FIGURE 3 KEY INDUSTRY INSIGHTS 40
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 40
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 41
2.2 MARKET SIZE ESTIMATION 41
2.2.1 BOTTOM-UP APPROACH 41
FIGURE 6 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 42
FIGURE 7 APPROACH 3: PARENT MARKET ANALYSIS (ULTRASOUND MARKET) 43
2.2.1.1 Growth forecast 43
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 43
FIGURE 9 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 44
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 45
FIGURE 10 DATA TRIANGULATION METHODOLOGY 45
2.4 MARKET SHARE ANALYSIS 46
2.5 STUDY ASSUMPTIONS 46
2.6 RISK ASSESSMENT 46
2.7 IMPACT OF RECESSION 47
3 EXECUTIVE SUMMARY 48
FIGURE 11 FETAL MONITORING MARKET, BY PRODUCT, 2022 VS. 2027 (USD BILLION) 48
FIGURE 12 FETAL MONITORING MARKET, BY PORTABILITY, 2022 VS. 2027 (USD BILLION) 49
FIGURE 13 FETAL MONITORING MARKET, BY METHOD, 2022 VS. 2027 (USD BILLION) 49
FIGURE 14 FETAL MONITORING MARKET, BY APPLICATION, 2022 VS. 2027 (USD BILLION) 50
FIGURE 15 FETAL MONITORING MARKET, BY END USER, 2022 VS. 2027 (USD BILLION) 50
FIGURE 16 REGIONAL SNAPSHOT OF FETAL MONITORING MARKET 51
4 PREMIUM INSIGHTS 52
4.1 FETAL MONITORING MARKET OVERVIEW 52
FIGURE 17 RISING PRETERM BIRTHS TO DRIVE FETAL MONITORING MARKET 52
4.2 ASIA PACIFIC: FETAL MONITORING MARKET, BY METHOD (2021) 53
FIGURE 18 NON-INVASIVE METHODS ACCOUNTED FOR LARGEST SHARE IN 2021 53
4.3 REGIONAL GROWTH OPPORTUNITIES IN FETAL MONITORING MARKET 54
FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 54
4.4 FETAL MONITORING MARKET: REGIONAL MIX 54
FIGURE 20 ASIA PACIFIC MARKET TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD 54
4.5 FETAL MONITORING MARKET: DEVELOPED VS. DEVELOPING ECONOMIES 55
FIGURE 21 DEVELOPING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD 55
5 MARKET OVERVIEW 56
5.1 INTRODUCTION 56
5.2 MARKET DYNAMICS 56
FIGURE 22 FETAL MONITORING MARKET DYNAMICS 56
5.2.1 DRIVERS 57
5.2.1.1 Rising number of preterm births and increasing adoption of infertility treatment 57
5.2.1.2 Advanced and innovative fetal monitoring technologies 58
5.2.1.3 Government initiatives and increasing collaborations for research by health agencies 59
5.2.1.4 Reimbursement and insurance policies for fetal monitoring services 59
TABLE 4 CPT CODES FOR VAGINAL DELIVERIES 60
5.2.1.5 Active product launches by key manufacturers 60
5.2.1.6 Increasing number of obstetrics and gynecology centers for fetal monitoring 60
5.2.2 RESTRAINTS 61
5.2.2.1 High costs of fetal monitoring equipment 61
5.2.2.2 Availability of refurbished products 61
5.2.3 OPPORTUNITIES 61
5.2.3.1 Development of non-invasive, portable, and advanced fetal monitors 61
5.2.3.2 Emerging markets and strengthening infrastructure 62
5.2.4 CHALLENGES 62
5.2.4.1 Product recalls 62
TABLE 5 PRODUCT RECALLS IN FETAL MONITORING MARKET 62
5.2.4.2 Lack of skilled healthcare professionals 63
5.3 SUPPLY CHAIN ANALYSIS 63
FIGURE 23 DIRECT DISTRIBUTION – PREFERRED STRATEGY OF PROMINENT COMPANIES 64
5.4 VALUE CHAIN ANALYSIS 64
FIGURE 24 FETAL MONITORING MARKET: VALUE CHAIN ANALYSIS 64
5.5 ECOSYSTEM ANALYSIS 65
FIGURE 25 FETAL MONITORING MARKET: ECOSYSTEM ANALYSIS 65
5.5.1 ROLE IN ECOSYSTEM 66
FIGURE 26 KEY PLAYERS IN FETAL MONITORING MARKET ECOSYSTEM 66
5.6 REGULATORY LANDSCAPE 67
TABLE 6 REGULATORY AUTHORITIES 67
5.6.1 EU REGULATIONS 68
5.6.2 US REGULATIONS 68
5.7 PORTER’S FIVE FORCES ANALYSIS 68
5.7.1 THREAT FROM NEW ENTRANTS 69
5.7.2 BARGAINING POWER OF SUPPLIERS 69
5.7.3 BARGAINING POWER OF BUYERS 69
5.7.4 INTENSITY OF COMPETITIVE RIVALRY 69
5.7.5 THREAT OF SUBSTITUTES 69
5.8 PATENT ANALYSIS OF FETAL MONITORING PRODUCTS 70
FIGURE 27 PATENT ANALYSIS: UTERINE CONTRACTION MONITORS (2013–NOVEMBER 2022) 70
FIGURE 28 PATENT ANALYSIS: FETAL DOPPLERS (2013–NOVEMBER 2022) 71
FIGURE 29 PATENT ANALYSIS: FETAL ELECTRODES (2013–NOVEMBER 2022) 72
5.9 TRADE ANALYSIS FOR ULTRASOUND 73
5.9.1 IMPORT DATA FOR ULTRASOUND, BY COUNTRY, 2017–2021 (USD MILLION) 73
5.9.2 EXPORT DATA FOR ULTRASOUND, BY COUNTRY, 2017–2021 (USD MILLION) 73
5.10 TECHNOLOGY ANALYSIS 74
TABLE 7 AVERAGE SELLING PRICE OF FETAL MONITORING PRODUCTS 74
6 FETAL MONITORING MARKET, BY PRODUCT 76
6.1 INTRODUCTION 77
TABLE 8 FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 77
6.2 ULTRASOUND DEVICES 77
TABLE 9 ULTRASOUND DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 78
TABLE 10 ULTRASOUND DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 78
6.2.1 2D ULTRASOUND 78
6.2.1.1 Increasing commercialization of innovative 2D technologies 78
TABLE 11 2D ULTRASOUND: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION) 79
6.2.2 3D & 4D ULTRASOUND 79
6.2.2.1 Technological advantages of 3D & 4D ultrasound over 2D ultrasound 79
TABLE 12 3D & 4D ULTRASOUND: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION) 80
6.2.3 DOPPLER IMAGING 80
6.2.3.1 Doppler imaging vital to analyze hemodynamics in fetal surveillance 80
TABLE 13 DOPPLER IMAGING: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION) 81
6.3 ELECTRONIC MATERNAL/FETAL MONITORS 81
6.3.1 RISING NUMBER OF HIGH-RISK PREGNANCIES 81
TABLE 14 ELECTRONIC MATERNAL/FETAL MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 82
6.4 FETAL ELECTRODES 82
6.4.1 NEED FOR INTRAPARTUM FETAL SURVEILLANCE 82
TABLE 15 FETAL ELECTRODES MARKET, BY REGION, 2020–2027 (USD MILLION) 82
6.5 FETAL DOPPLER DEVICES 83
6.5.1 INCREASING USE OF FETAL DOPPLERS IN-HOME CARE SETTINGS 83
TABLE 16 FETAL DOPPLER DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 83
6.6 UTERINE CONTRACTION MONITORS 84
TABLE 17 UTERINE CONTRACTION MONITORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 84
TABLE 18 UTERINE CONTRACTION MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 84
6.6.1 INTERNAL UTERINE CONTRACTION MONITORS 84
6.6.1.1 Accurate measurements obtained by internal UCMs 84
TABLE 19 INTERNAL UTERINE CONTRACTION MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 85
6.6.2 EXTERNAL UTERINE CONTRACTION MONITORS 85
6.6.2.1 Developments underway to overcome drawbacks of external UCMs 85
TABLE 20 EXTERNAL UTERINE CONTRACTION MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 86
6.7 TELEMETRY DEVICES 86
6.7.1 REMOTE MONITORING INCORPORATED INTO TELEMETRY DEVICES 86
TABLE 21 TELEMETRY DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 87
6.8 ACCESSORIES & CONSUMABLES 87
6.8.1 ADVANCEMENTS IN FETAL MONITORING TO LEAD TO INCREASING UTILIZATION OF ACCESSORIES & CONSUMABLES 87
TABLE 22 ACCESSORIES & CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION) 87
6.9 OTHER PRODUCTS 88
TABLE 23 OTHER PRODUCTS MARKET, BY REGION, 2020–2027 (USD MILLION) 88
7 FETAL MONITORING MARKET, BY PORTABILITY 89
7.1 INTRODUCTION 90
TABLE 24 FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION) 90
7.2 NON-PORTABLE SYSTEMS 90
7.2.1 TECHNOLOGICAL ADVANCEMENTS IN NON-PORTABLE SYSTEMS TO SUPPORT MARKET GROWTH 90
TABLE 25 NON-PORTABLE SYSTEMS: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION) 91
7.3 PORTABLE SYSTEMS 91
7.3.1 REMOTE ACCURACY OFFERED BY PORTABLE SYSTEMS TO DRIVE MARKET GROWTH 91
TABLE 26 PORTABLE SYSTEMS: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION) 92
8 FETAL MONITORING MARKET, BY METHOD 93
8.1 INTRODUCTION 94
TABLE 27 FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION) 94
8.2 NON-INVASIVE METHOD 94
8.2.1 NON-INVASIVE METHODS WIDELY ADOPTED IN HIGH-RISK PREGNANCIES 94
TABLE 28 NON-INVASIVE FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION) 95
8.3 INVASIVE METHOD 95
8.3.1 CONSISTENT TRANSMISSION OF FETAL HEART RATE POSSIBLE VIA INVASIVE METHODS 95
TABLE 29 INVASIVE FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION) 96
9 FETAL MONITORING MARKET, BY APPLICATION 97
9.1 INTRODUCTION 98
TABLE 30 FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 98
9.2 ANTEPARTUM 98
9.2.1 INCREASING INCIDENCES OF PREGNANCY-RELATED COMPLICATIONS TO SUPPORT GROWTH 98
TABLE 31 ANTEPARTUM FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION) 99
9.3 INTRAPARTUM 99
9.3.1 FAVORABLE GUIDELINES BY HEALTHCARE AUTHORITIES TO PROPEL GROWTH 99
TABLE 32 INTRAPARTUM FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION) 100
10 FETAL MONITORING MARKET, BY END USER 101
10.1 INTRODUCTION 102
TABLE 33 FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION) 102
10.2 HOSPITALS 102
10.2.1 AVAILABILITY OF WELL-ESTABLISHED HEALTHCARE INFRASTRUCTURE TO DRIVE SEGMENT GROWTH 102
TABLE 34 HOSPITALS: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION) 103
10.3 OBSTETRICS & GYNECOLOGY CLINICS 103
10.3.1 RISING EMPHASIS ON PERINATAL CARE TO BOLSTER GROWTH OF SEGMENT 103
TABLE 35 OBSTETRICS & GYNECOLOGY CLINICS: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION) 104
10.4 HOME CARE SETTINGS 104
10.4.1 REMOTE CARE BY PORTABLE FETAL MONITORING SYSTEMS TO DRIVE GROWTH 104
TABLE 36 HOME CARE SETTINGS: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION) 105
11 FETAL MONITORING MARKET, BY REGION 106
11.1 INTRODUCTION 107
TABLE 37 FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION) 107
11.2 NORTH AMERICA 107
FIGURE 30 NORTH AMERICA: FETAL MONITORING MARKET SNAPSHOT 108
TABLE 38 NORTH AMERICA: FETAL MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 108
TABLE 39 NORTH AMERICA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 109
TABLE 40 NORTH AMERICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION) 109
TABLE 41 NORTH AMERICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION) 110
TABLE 42 NORTH AMERICA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION) 110
TABLE 43 NORTH AMERICA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION) 110
TABLE 44 NORTH AMERICA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 111
TABLE 45 NORTH AMERICA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION) 111
11.2.1 RECESSION IMPACT 111
11.2.2 US 112
11.2.2.1 US held largest share of North American market in 2021 112
FIGURE 31 US: PRETERM BIRTH RATE, BY RACE/ETHNICITY, 2018–2020 (AVERAGE) 112
TABLE 46 ULTRASOUND CPT CODES 113
TABLE 47 US: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 114
TABLE 48 US: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 US: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION) 115
TABLE 50 US: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION) 115
TABLE 51 US: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION) 115
TABLE 52 US: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 116
TABLE 53 US: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION) 116
11.2.3 CANADA 116
11.2.3.1 Growing government initiatives for fetal and maternal care to drive market growth in Canada 116
FIGURE 32 CANADA: NUMBER OF BIRTHS, 2011 TO 2021 117
TABLE 54 CANADA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 118
TABLE 55 CANADA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 56 CANADA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 57 CANADA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION) 119
TABLE 58 CANADA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION) 119
TABLE 59 CANADA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 120
TABLE 60 CANADA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION) 120
11.3 EUROPE 120
TABLE 61 EUROPE: FETAL MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 121
TABLE 62 EUROPE: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 121
TABLE 63 EUROPE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION) 122
TABLE 64 EUROPE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION) 122
TABLE 65 EUROPE: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION) 122
TABLE 66 EUROPE: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION) 123
TABLE 67 EUROPE: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION) 123
11.3.1 RECESSION IMPACT 124
11.3.2 GERMANY 124
11.3.2.1 Increasing healthcare expenditure to support market growth in Germany 124
TABLE 69 GERMANY: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 125
TABLE 70 GERMANY: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 71 GERMANY: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION) 126
TABLE 72 GERMANY: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION) 126
TABLE 73 GERMANY: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION) 126
TABLE 74 GERMANY: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 127
TABLE 75 GERMANY: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION) 127
11.3.3 UK 127
11.3.3.1 Rising emphasis on better maternity services to drive market growth in UK 127
TABLE 76 UK: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 128
TABLE 77 UK: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 78 UK: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 79 UK: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION) 129
TABLE 80 UK: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION) 129
TABLE 81 UK: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 130
TABLE 82 UK: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION) 130
11.3.4 FRANCE 130
11.3.4.1 Increasing focus on healthcare policies to accelerate market growth in France 130
TABLE 83 FRANCE: HEALTHCARE SPENDING, 2011–2019 131
TABLE 84 FRANCE: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 132
TABLE 85 FRANCE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 86 FRANCE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION) 133
TABLE 87 FRANCE: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION) 133
TABLE 88 FRANCE: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION) 133
TABLE 89 FRANCE: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 134
TABLE 90 FRANCE: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION) 134
11.3.5 ITALY 134
11.3.5.1 Increasing healthcare expenditure to propel growth of market in Italy 134
TABLE 91 ITALY: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 135
TABLE 92 ITALY: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 93 ITALY: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 94 ITALY: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION) 136
TABLE 95 ITALY: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION) 136
TABLE 96 ITALY: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 136
TABLE 97 ITALY: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION) 137
11.3.6 SPAIN 137
11.3.6.1 Declining birth rate to restrain growth of market in Spain 137
TABLE 98 SPAIN: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 138
TABLE 99 SPAIN: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 100 SPAIN: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 101 SPAIN: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION) 139
TABLE 102 SPAIN: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION) 139
TABLE 103 SPAIN: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 SPAIN: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION) 140
11.3.7 REST OF EUROPE 140
TABLE 105 REST OF EUROPE: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 141
TABLE 106 REST OF EUROPE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION) 141
TABLE 107 REST OF EUROPE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION) 142
TABLE 108 REST OF EUROPE: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION) 142
TABLE 109 REST OF EUROPE: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION) 142
TABLE 110 REST OF EUROPE: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 143
TABLE 111 REST OF EUROPE: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION) 143
11.4 ASIA PACIFIC 143
FIGURE 33 ASIA PACIFIC: FETAL MONITORING MARKET SNAPSHOT 144
11.4.1 RECESSION IMPACT 144
TABLE 112 ASIA PACIFIC: FETAL MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 145
TABLE 113 ASIA PACIFIC: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 145
TABLE 114 ASIA PACIFIC: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 115 ASIA PACIFIC: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 116 ASIA PACIFIC: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION) 146
TABLE 117 ASIA PACIFIC: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION) 147
TABLE 118 ASIA PACIFIC: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 147
TABLE 119 ASIA PACIFIC: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION) 147
11.4.2 JAPAN 148
11.4.2.1 Increasing focus on launch of innovative products to propel market growth in Japan 148
TABLE 120 JAPAN: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 149
TABLE 121 JAPAN: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 122 JAPAN: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 123 JAPAN: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION) 150
TABLE 124 JAPAN: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION) 150
TABLE 125 JAPAN: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 126 JAPAN: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION) 151
11.4.3 CHINA 151
11.4.3.1 Developing healthcare infrastructure in China to support market growth 151
TABLE 127 CHINA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 152
TABLE 128 CHINA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 129 CHINA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 130 CHINA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION) 153
TABLE 131 CHINA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION) 153
TABLE 132 CHINA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION) 154
11.4.4 INDIA 154
11.4.4.1 Growing number of preterm births to drive market growth in India 154
TABLE 134 INDIA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 155
TABLE 135 INDIA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 INDIA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 137 INDIA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION) 156
TABLE 138 INDIA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION) 156
TABLE 139 INDIA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 156
TABLE 140 INDIA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION) 157
11.4.5 SOUTH KOREA 157
11.4.5.1 Increasing implementation of ultrasound technology to drive market in South Korea 157
TABLE 141 SOUTH KOREA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 158
TABLE 142 SOUTH KOREA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION) 158
TABLE 143 SOUTH KOREA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION) 158
TABLE 144 SOUTH KOREA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION) 159
TABLE 145 SOUTH KOREA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION) 159
TABLE 146 SOUTH KOREA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 159
TABLE 147 SOUTH KOREA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION) 160
11.4.6 AUSTRALIA 160
11.4.6.1 Rising emphasis on maternal care to bolster market growth in Australia 160
TABLE 148 AUSTRALIA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 161
TABLE 149 AUSTRALIA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 150 AUSTRALIA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 151 AUSTRALIA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION) 162
TABLE 152 AUSTRALIA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION) 162
TABLE 153 AUSTRALIA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 163
TABLE 154 AUSTRALIA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION) 163
11.4.7 REST OF ASIA PACIFIC 163
TABLE 155 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 164
TABLE 156 REST OF ASIA PACIFIC: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION) 164
TABLE 157 REST OF ASIA PACIFIC: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 158 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION) 165
TABLE 159 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION) 165
TABLE 160 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 166
TABLE 161 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION) 166
11.5 REST OF THE WORLD 166
11.5.1 RECESSION IMPACT 166
TABLE 162 REST OF THE WORLD: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION) 167
TABLE 163 REST OF THE WORLD: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 167
TABLE 164 REST OF THE WORLD: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 165 REST OF THE WORLD: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 166 REST OF THE WORLD: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION) 168
TABLE 167 REST OF THE WORLD: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION) 169
TABLE 168 REST OF THE WORLD: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 169
TABLE 169 REST OF THE WORLD: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION) 169
11.5.2 LATIN AMERICA 170
11.5.2.1 Favorable government policies to support growth of market 170
TABLE 170 LATIN AMERICA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 170
TABLE 171 LATIN AMERICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 172 LATIN AMERICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 173 LATIN AMERICA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION) 171
TABLE 174 LATIN AMERICA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION) 172
TABLE 175 LATIN AMERICA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 176 LATIN AMERICA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION) 172
11.5.3 MIDDLE EAST & AFRICA 173
11.5.3.1 High number of pre-term births recorded to boost market 173
TABLE 177 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 174
TABLE 178 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 179 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION) 175
TABLE 181 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION) 175
TABLE 182 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 176
TABLE 183 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION) 176
12 COMPETITIVE LANDSCAPE 177
12.1 OVERVIEW 177
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 177
TABLE 184 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES 177
12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 178
FIGURE 34 REVENUE SHARE ANALYSIS OF TOP PLAYERS 178
12.4 MARKET SHARE ANALYSIS 179
FIGURE 35 FETAL MONITORING MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 179
12.5 COMPANY EVALUATION QUADRANT (2021) 180
12.5.1 STARS 180
12.5.2 EMERGING LEADERS 180
12.5.3 PERVASIVE PLAYERS 181
12.5.4 PARTICIPANTS 181
FIGURE 36 FETAL MONITORING MARKET: COMPANY EVALUATION QUADRANT, 2021 181
12.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2021) 182
12.6.1 PROGRESSIVE COMPANIES 182
12.6.2 STARTING BLOCKS 182
12.6.3 RESPONSIVE COMPANIES 182
12.6.4 DYNAMIC COMPANIES 182
FIGURE 37 FETAL MONITORING MARKET: START-UP/SME EVALUATION QUADRANT, 2021 183
12.7 COMPETITIVE BENCHMARKING 184
TABLE 185 FETAL MONITORING MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS 184
TABLE 186 PRODUCT FOOTPRINT OF KEY PLAYERS 185
TABLE 187 REGIONAL FOOTPRINT OF KEY PLAYERS 186
12.8 COMPETITIVE SCENARIO 187
12.8.1 PRODUCT LAUNCHES 187
TABLE 188 PRODUCT LAUNCHES, 2019–NOVEMBER 2022 187
12.8.2 DEALS 188
TABLE 189 DEALS, 2019–NOVEMBER 2022 188
12.8.3 OTHER DEVELOPMENTS 189
TABLE 190 OTHER DEVELOPMENTS, 2019–NOVEMBER 2022 189
13 COMPANY PROFILES 190
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
13.1 KEY PLAYERS 190
13.1.1 GE HEALTHCARE 190
TABLE 191 GE HEALTHCARE: BUSINESS OVERVIEW 190
FIGURE 38 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT 191
TABLE 192 GE HEALTHCARE: PRODUCTS OFFERED 191
TABLE 193 GE HEALTHCARE: DEALS 192
13.1.2 SIEMENS HEALTHINEERS 194
TABLE 194 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW 194
FIGURE 39 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT 195
TABLE 195 SIEMENS HEALTHINEERS: PRODUCTS OFFERED 195
TABLE 196 SIEMENS HEALTHINEERS: DEALS 196
13.1.3 CARDINAL HEALTH, INC. 197
TABLE 197 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW 197
FIGURE 40 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT 198
TABLE 198 CARDINAL HEALTH, INC.: PRODUCTS OFFERED 198
13.1.4 KONINKLIJKE PHILIPS N.V. 200
TABLE 199 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 200
FIGURE 41 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 201
TABLE 200 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 201
TABLE 201 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES 202
13.1.5 FUJIFILM SONOSITE, INC. 204
TABLE 202 FUJIFILM SONOSITE, INC.: BUSINESS OVERVIEW 204
FIGURE 42 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT 205
TABLE 203 FUJIFILM SONOSITE, INC.: PRODUCTS OFFERED 205
TABLE 204 FUJIFILM SONOSITE, INC.: PRODUCT LAUNCHES 206
TABLE 205 FUJIFILM SONOSITE, INC.: DEALS 206
13.1.6 HUNTLEIGH HEALTHCARE LIMITED 208
TABLE 206 HUNTLEIGH HEALTHCARE LIMITED: BUSINESS OVERVIEW 208
FIGURE 43 ARJO: COMPANY SNAPSHOT 208
TABLE 207 HUNTLEIGH HEALTHCARE LIMITED: PRODUCTS OFFERED 209
13.1.7 NATUS MEDICAL INCORPORATED 210
TABLE 208 NATUS MEDICAL INCORPORATED: BUSINESS OVERVIEW 210
FIGURE 44 NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT 210
TABLE 209 NATUS MEDICAL INCORPORATED: PRODUCTS OFFERED 211
TABLE 210 NATUS MEDICAL INCORPORATED: DEALS 211
13.1.8 THE COOPER COMPANIES, INC. 212
TABLE 211 THE COOPER COMPANIES, INC.: BUSINESS OVERVIEW 212
FIGURE 45 THE COOPER COMPANIES, INC.: COMPANY SNAPSHOT 213
TABLE 212 THE COOPER COMPANIES, INC.: PRODUCTS OFFERED 213
TABLE 213 THE COOPER COMPANIES, INC.: DEALS 214
13.1.9 CONTEC MEDICAL SYSTEMS CO., LTD. 215
TABLE 214 CONTEC MEDICAL SYSTEMS CO., LTD.: BUSINESS OVERVIEW 215
TABLE 215 CONTEC MEDICAL SYSTEMS CO., LTD.: PRODUCTS OFFERED 215
TABLE 216 CONTEC MEDICAL SYSTEMS CO., LTD.: PRODUCT LAUNCHES 216
TABLE 217 CONTEC MEDICAL SYSTEMS CO., LTD.: DEALS 216
13.1.10 EDAN INSTRUMENTS, INC. 217
TABLE 218 EDAN INSTRUMENTS, INC.: BUSINESS OVERVIEW 217
TABLE 219 EDAN INSTRUMENTS, INC.: PRODUCTS OFFERED 217
TABLE 220 EDAN INSTRUMENTS, INC.: DEALS 218
TABLE 221 EDAN INSTRUMENTS, INC.: OTHER DEVELOPMENTS 218
13.2 OTHER PLAYERS 219
13.2.1 NEOVENTA MEDICAL AB 219
13.2.2 BIONET CO., LTD. 220
13.2.3 PROGETTI SRL 220
13.2.4 TRISMED CO., LTD. 221
13.2.5 SHENZHEN LUCKCOME TECHNOLOGY INC., LTD. 221
13.2.6 MEDGYN PRODUCTS, INC. 222
13.2.7 DIXION 223
13.2.8 PROMED TECHNOLOGY CO., LTD. 224
13.2.9 ADVANCED INSTRUMENTATIONS 225
13.2.10 BRAEL-MEDICAL EQUIPMENT 226
13.2.11 GPC MEDICAL LTD. 227
13.2.12 SHENZHEN VCOMIN TECHNOLOGY LIMITED 228
13.2.13 BISTOS CO., LTD. 229
13.2.14 MEDIANA CO., LTD. 230
13.2.15 LIFE PLUS HEALTHCARE (P) LTD. 231
13.2.16 CHOICEMMED 232
13.2.17 TRIVITRON HEALTHCARE 233
13.2.18 DOTT MEDICAL CO. LTD. 234
13.2.19 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD. 235
13.2.20 NEMO HEALTHCARE 235
13.2.21 MINDCHILD MEDICAL, INC. 236
13.2.22 MELODY INTERNATIONAL LTD. 236
13.2.23 JANITRI INNOVATIONS PVT. LTD. 237
13.2.24 LAERDAL GLOBAL HEALTH 237
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.

14 APPENDIX 238
14.1 INDUSTRY INSIGHTS 238
14.2 DISCUSSION GUIDE 239
14.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 243
14.4 CUSTOMIZATION OPTIONS 245
14.5 RELATED REPORTS 245
14.6 AUTHOR DETAILS 246


    お問合せフォーム

    • レポートのタイトルは自動で入ります。

    • *のある項目は必須項目です。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com